Skip to main content

Table 2 Number of institutions involved in drug, diagnostics, vaccines, and traditional medicine development in the ASEAN

From: A look at the ASEAN-NDI: building a regional health R&D innovation network

DRUG DEVELOPMENT

Country

No. involved in Drug Development

No. involved in Target Discovery

No. involved in Screening

No. involved in Product Development

No. involved in Clinical Trials

No. involved in Manufacturing

No. involved in M&E

Bruneia

-

-

-

-

-

-

-

Cambodiac

20

10

-

2

-

10

10

Indonesiab

40

22

23

14

18

9

16

Laosb

3

-

-

-

-

-

-

Malaysiab

33

10

6

7

3

1

3

Myanmarc

19

14

3

-

2

-

2

Philippinesb

19

6

6

3

9

2

7

Singapored

6

6

-

4

1

-

1

Thailandc

90

59

-

12

27

-

33

Vietnamb

18

4

-

6

6

12

-

DIAGNOSTICS DEVELOPMENT

Country

No. involved in Diagnostics Development

No. involved in Target Discovery

Platform Development

No. involved in Product Development

No. involved in Clinical Trials

No. involved in Manufacturing

No. involved in M&E

Bruneia

-

-

-

-

-

-

-

Cambodiac

4

-

-

1

2

 

2

Indonesiab

21

16

1

4

-

2

18

Laosb

-

-

-

-

-

-

-

Malaysiab

50

15

12

11

6

-

6

Myanmarc

2

-

-

-

1

-

1

Philippinesb

13

11

 

8

6

2

1

Singaporee

5/546

5

4

-

-

-

5

Thailandc

31

6

8

3

-

-

15

Vietnamb

7

4

5

4

1

2

-

VACCINES DEVELOPMENT

Country

No. involved in Vaccine Development

No. involved in Target Discovery

No. involved in Screening

No. involved in Vaccine Development

No. involved in Clinical Trials

No. involved in Manufacturing

No. involved in M&E

Bruneia

-

-

-

-

-

-

-

Cambodiab

14

8

1

-

-

-

1

Indonesia

14

2

-

7

2

2

1

Laosa

-

-

-

-

-

-

-

Malaysiab

9

4

-

2

2

-

1

Myanmarb

9

1

8

-

-

-

-

Philippinesb

12

6

1

1

5

1

1

Singaporef

4/110

4

4

-

-

-

-

Thailandb

21

12

4

2

-

-

5

Vietnamg

6

-

-

-

-

5

-

TRADITIONAL MEDICINE DEVELOPMENT

Country

No. involved in Traditional Medicine Development

No. involved in Target Discovery

No. involved in Screening

No. involved in Product Development

No. involved in Clinical Trials

No. involved in Manufacturing

No. involved in M&E

Bruneia

-

-

-

-

-

-

-

Cambodiac

2

-

-

-

-

-

-

Indonesiab

16

7

  

2

1

2

Laosb

-

-

-

-

-

 

-

Malaysiab

188

8

5

6

2

-

2

Myanmarc

-

-

-

-

-

-

-

Philippinesc

16

12

14

8

4

3

1

Singaporeh

-

-

-

-

-

-

-

Thailandc

4

2

-

2

-

-

-

Vietnamb

12

5

6

5

3

7

-

  1. Sources: Scopus (Elsevier, 2010) and country reports.
  2. aNo specific information available.
  3. bData based on the country report.
  4. cData from internet sources.
  5. dAlthough based on the country report, this does not summarize the R&D in Singapore.
  6. eThe country report states five institutions while internet sources indicate as many as 546 institutions.
  7. fThe country report states four institutions while the internet source cites 110 institutions.
  8. gThe involvement of institutions in the specific stage of development is not available in the supplied information.
  9. hNo data available for Singapore.
Back to article page

Infectious Diseases of Poverty

ISSN: 2049-9957

Contact us